Triple
T22357665
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Royal Society Science Book Prize |
E552695
|
entity |
| Predicate | sponsor |
P67
|
FINISHED |
| Object | Rhône-Poulenc |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Rhône-Poulenc | Statement: [Royal Society Science Book Prize, sponsor, Rhône-Poulenc]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Rhône-Poulenc Context triple: [Royal Society Science Book Prize, sponsor, Rhône-Poulenc]
-
A.
Rhône-Poulenc Rorer
Rhône-Poulenc Rorer was a major French-American pharmaceutical company known for developing important cancer therapies and later becoming part of Sanofi through mergers.
-
B.
Smith, Kline & French
Smith, Kline & French was a major 20th-century pharmaceutical company known for developing and marketing important prescription drugs before becoming part of GlaxoSmithKline.
-
C.
Ciba-Geigy
Ciba-Geigy was a major Swiss pharmaceutical and chemical company that became one of the predecessors of Novartis after its merger with Sandoz in 1996.
-
D.
Schering
Schering is a German surname most notably associated with Ernst Schering, a 19th-century pharmacist and founder of the pharmaceutical company Schering AG.
-
E.
Roche
Roche is a village and civil parish in Cornwall, England, known for its distinctive granite outcrop and historic chapel perched on Roche Rock.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Rhône-Poulenc Target entity description: Rhône-Poulenc was a major French chemical and pharmaceutical company known for its significant role in the global life sciences industry and for sponsoring prominent scientific initiatives.
-
A.
Rhône-Poulenc Rorer
chosen
Rhône-Poulenc Rorer was a major French-American pharmaceutical company known for developing important cancer therapies and later becoming part of Sanofi through mergers.
-
B.
Smith, Kline & French
Smith, Kline & French was a major 20th-century pharmaceutical company known for developing and marketing important prescription drugs before becoming part of GlaxoSmithKline.
-
C.
Ciba-Geigy
Ciba-Geigy was a major Swiss pharmaceutical and chemical company that became one of the predecessors of Novartis after its merger with Sandoz in 1996.
-
D.
Schering
Schering is a German surname most notably associated with Ernst Schering, a 19th-century pharmacist and founder of the pharmaceutical company Schering AG.
-
E.
Roche
Roche is a village and civil parish in Cornwall, England, known for its distinctive granite outcrop and historic chapel perched on Roche Rock.
- F. None of above.
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e11e4a0ad08190a385b4d343cf6524 |
completed | April 16, 2026, 5:37 p.m. |
| NER | Named-entity recognition | batch_69f157d1a87c8190a3e195cfbbb0d64f |
completed | April 29, 2026, 12:58 a.m. |
Created at: April 16, 2026, 8:44 p.m.